<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
REGN
Regeneron
$
()


  • Regeneron presents follow-up data from pivotal Phase 1/2 LINKER-MM1 trial

    6/16/2024 - 07:21am
  • Regeneron price target raised by $29 at RBC Capital, here's why

    6/12/2024 - 07:24am
  • Regeneron price target raised by $75 at Wells Fargo, here's why

    6/12/2024 - 06:22am
  • Mylan injunction an 'incremental positive' for Regeneron, says Morgan Stanley

    6/11/2024 - 14:51pm
  • Regeneron, Sanofi announce FDA approved Kevzara for treatment of pJIA

    6/11/2024 - 07:02am
  • Biotech Alert: Searches spiking for these stocks today

    6/6/2024 - 11:01am
  • Biotech Alert: Searches spiking for these stocks today

    6/5/2024 - 10:59am
  • Regeneron price target raised by $15 at RBC Capital, here's why

    6/4/2024 - 08:02am
  • FibroGen, Regeneron in deal for oncology assets in evaluation combo study

    6/3/2024 - 16:17pm
  • Regeneron, Sanofi report FDA extension of target action date for Dupixent review

    5/31/2024 - 05:22am
  • Regeneron, Sanofi announce CHMP opinion recommending approval of Dupixent

    5/31/2024 - 05:18am
  • Jefferies healthcare analyst holds an analyst/industry conference call

    5/24/2024 - 11:22am
  • Sensei Biotherapeutics' SNS-101 shows potential efficacy in Phase 1/2 trial

    5/23/2024 - 17:18pm
  • Regeneron reports 'positive' results from REGN7075 Phase 2 trial

    5/23/2024 - 17:04pm
  • Sanofi says NOTUS data confirm positive Phase 3 BOREAS study

    5/20/2024 - 14:20pm
dynamic_feed Breaking News